Literature DB >> 10098775

Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.

O Díez1, A Osorio, M Robledo, A Barroso, M Domènech, J Cortés, J Albertos, J Sanz, J Brunet, J M SanRomán, M C Alonso, M Baiget, J Benítez.   

Abstract

We screened the 185delAG and 5382insC (BRCA1) and the 6174delT (BRCA2) mutation in 298 Spanish women with breast cancer. Two women (one with Sephardic ancestors) presented the 185delAG mutation and the same haplotype reported in Ashkenazim with this mutation. This suggests a common origin of the 185delAG in both Sephardic and Ashkenazi populations.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10098775      PMCID： PMC2362239          DOI： 10.1038/sj.bjc.6690208

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  6 in total

1.  A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.

Authors:  D B Berman; J Costalas; D C Schultz; G Grana; M Daly; A K Godwin
Journal:  Cancer Res       Date:  1996-08-01       Impact factor: 12.701

2.  The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

Authors:  R B Bar-Sade; A Kruglikova; B Modan; E Gak; G Hirsh-Yechezkel; L Theodor; I Novikov; R Gershoni-Baruch; S Risel; M Z Papa; G Ben-Baruch; E Friedman
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

3.  BRCA1 mutations in Ashkenazi Jewish women.

Authors:  P Tonin; O Serova; G Lenoir; H Lynch; F Durocher; J Simard; K Morgan; S Narod
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

4.  Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.

Authors:  B B Roa; A A Boyd; K Volcik; C S Richards
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

5.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

6.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Authors:  S L Neuhausen; S Mazoyer; L Friedman; M Stratton; K Offit; A Caligo; G Tomlinson; L Cannon-Albright; T Bishop; D Kelsell; E Solomon; B Weber; F Couch; J Struewing; P Tonin; F Durocher; S Narod; M H Skolnick; G Lenoir; O Serova; B Ponder; D Stoppa-Lyonnet; D Easton; M C King; D E Goldgar
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025
  6 in total
  11 in total

1.  Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.

Authors:  Yael Laitman; Bing-Jian Feng; Itay M Zamir; Jeffrey N Weitzel; Paul Duncan; Danielle Port; Eswary Thirthagiri; Soo-Hwang Teo; Gareth Evans; Ayse Latif; William G Newman; Ruth Gershoni-Baruch; Jamal Zidan; Shani Shimon-Paluch; David Goldgar; Eitan Friedman
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

2.  Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing.

Authors:  Orland Diez; Sara Gutiérrez-Enríquez; Judith Balmaña
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

3.  Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.

Authors:  Gabriela Torres-Mejía; Robert Royer; Marcia Llacuachaqui; Mohammad R Akbari; Anna R Giuliano; Louis Martínez-Matsushita; Angélica Angeles-Llerenas; Carolina Ortega-Olvera; Elad Ziv; Eduardo Lazcano-Ponce; Catherine M Phelan; Steven A Narod
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-04       Impact factor: 4.254

4.  Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.

Authors:  F X Real; N Malats; G Lesca; M Porta; S Chopin; G M Lenoir; O Sinilnikova
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 5.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  Performance of BRCA1/2 mutation prediction models in Asian Americans.

Authors:  Allison W Kurian; Gail D Gong; Nicolette M Chun; Meredith A Mills; Ashley D Staton; Kerry E Kingham; Beth B Crawford; Robin Lee; Salina Chan; Susan S Donlon; Yolanda Ridge; Karen Panabaker; Dee W West; Alice S Whittemore; James M Ford
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

7.  Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry.

Authors:  Allison W Kurian; Gail D Gong; Esther M John; Alexander Miron; Anna Felberg; Amanda I Phipps; Dee W West; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

8.  Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing.

Authors:  Uta Francke; Cheri Dijamco; Amy K Kiefer; Nicholas Eriksson; Bianca Moiseff; Joyce Y Tung; Joanna L Mountain
Journal:  PeerJ       Date:  2013-02-12       Impact factor: 2.984

9.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

10.  Breast feeding, parity and breast cancer subtypes in a Spanish cohort.

Authors:  Carmen M Redondo; Manuela Gago-Domínguez; Sara Miranda Ponte; Manuel Enguix Castelo; Xuejuan Jiang; Ana Alonso García; Maite Peña Fernández; María Ausencia Tomé; Máximo Fraga; Francisco Gude; María Elena Martínez; Víctor Muñoz Garzón; Ángel Carracedo; J Esteban Castelao
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.